misc image


In recent years, the search for effective treatments to address male sexual dysfunction has led to innovative therapies, among which Low-Intensity Shockwave Therapy (LISWT) has gained significant attention. The Softwave device, an FDA-approved technology, has emerged as a promising solution for enhancing male sexual function with the potential to restore erections after years of progressive decline. This therapy involves the application of low-intensity acoustic waves to targeted areas of the phallus to improve blood flow and restore erectile function.

Understanding Low Intensity Shockwave Therapy (LISWT)

Low-Intensity Shockwave Therapy operates on the principle of stimulating angiogenesis, the formation of new blood vessels, and improving blood flow to the penis. The Softwave device delivers controlled shockwaves to the genital area, initiating a series of biological responses that promote tissue regeneration, enhancing erectile function, and potentially treating conditions like erectile dysfunction (ED).

Current FDA Approval and Safety Profile

The device we use, the Softwave device, is FDA 510(k) cleared for activation of connective tissue,  pain reduction, Improved blood supply, treatment of chronic diabetic foot ulcers, and treatment of acute second-degree burns. Its approval underscores the safety and efficacy demonstrated through clinical trials, highlighting its potential as a viable treatment option.

Moreover, one of the notable advantages of LISWT using the Softwave device is its minimal invasiveness and absence of reported adverse effects. Unlike some conventional treatments for ED, such as medications or invasive procedures, LISWT poses minimal risks and is generally well-tolerated by patients.

Insights from Current Literature

Research into the efficacy of LISWT for male sexual function improvement has shown promising results. Several studies have reported positive outcomes regarding increased penile blood flow, improved erectile function, and overall patient satisfaction. However, it's important to note that while many studies have shown positive results, more extensive and longer-term research is needed to define the number of treatments and determine efficacy and long-lasting effects.

Potential Risks and Benefits

While LISWT using the Softwave device appears to be a safe treatment option, potential risks may include minor discomfort during the procedure or temporary mild bruising. When compared to more invasive treatments, these risks are relatively low and transient.

The potential benefits, on the other hand, are substantial. Patients undergoing LISWT may experience improved erectile function, enhanced sexual performance, and increased satisfaction with their sexual lives. Furthermore, the non-invasive nature of the treatment makes it an attractive option for individuals seeking alternatives to medications or invasive procedures.


Low-Intensity Shockwave Therapy using the Softwave device stands as a promising option for addressing male sexual dysfunction, particularly erectile dysfunction. Its FDA approval underscores its safety and efficacy, offering a non-invasive treatment option with minimal reported adverse effects. While current literature and clinical trials support its potential benefits, further research is needed to establish its long-term effectiveness.


Questions? Call us at 516-487-2700, email us or request a courtesy appointment online.